Toronto, Ontario (Newsfile Corp. - November 23, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Corporation"), a drug discovery company developing therapeutics to regenerate muscle
Canadian Net REIT Announces its Results for the Quarter Ended September 30, 2022, an Increase in its Per Unit Distributions for 2023 and Q1 2023 Monthly Distributions streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
-Proof of concept studies to be completed by YE-
Toronto, Ontario (Newsfile Corp. - November 3, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a drug discovery company developing
Toronto, Ontario (Newsfile Corp. - October 6, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) ("Satellos" or the "Corporation"), a drug discovery company aimed at developing therapeutics
Satellos Bioscience Inc Announces Licensing of Formulation Technology and Expanded Collaboration with NW PharmaTech Ltd finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.